HYPOPARATHYROIDISM
Clinical trials for HYPOPARATHYROIDISM explained in plain language.
Never miss a new study
Get alerted when new HYPOPARATHYROIDISM trials appear
Sign up with your email to follow new studies for HYPOPARATHYROIDISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise for Long-Term control of rare hormone disorder
Disease control OngoingThis study tests the long-term safety of a weekly injection called MBX 2109 in 60 adults with hypoparathyroidism, a condition where the body doesn't produce enough parathyroid hormone. Participants had already completed a 12-week treatment phase. The goal is to see if the drug re…
Matched conditions: HYPOPARATHYROIDISM
Phase: PHASE2 • Sponsor: MBX Biosciences • Aim: Disease control
Last updated May 26, 2026 05:25 UTC
-
New registry tracks Real-World use of parathyroid hormone therapy
Knowledge-focused OngoingThis study is a registry that collects information from over 1,300 people with chronic hypoparathyroidism to see how safe and effective the drug rhPTH(1-84) is over time in everyday medical practice. Participants receive their usual care and fill out questionnaires during routine…
Matched conditions: HYPOPARATHYROIDISM
Sponsor: Takeda • Aim: Knowledge-focused
Last updated May 26, 2026 05:22 UTC